# Bacteriophage‐Mimetic DNA Origami Needle for Targeted Membrane Penetration and Cytosolic Cargo Delivery

**Authors:** Anirban Samanta, Mette Galsgaard Malle, Emily Tsang, Marjan Omer, Mads K. Skaanning, Sarah Youssef, Jørgen Kjems, Kurt V. Gothelf

PMC · DOI: 10.1002/advs.202512844 · Advanced Science · 2026-01-09

## TL;DR

Scientists created a DNA-based needle inspired by bacteriophages to deliver drugs directly into cancer cells.

## Contribution

A synthetic DNA origami needle mimicking bacteriophages for targeted cytosolic drug delivery is developed.

## Key findings

- The DNA origami needle successfully targets and delivers cargo into SKBR3 cancer cells.
- Cytosolic delivery is confirmed using real-time tracking and confocal microscopy.
- A disulfide-linked payload is released in response to intracellular glutathione.

## Abstract

Inspired by the natural ability of bacteriophages to deliver genetic material directly into host cells, we employed a bottom‐up approach to construct a multifunctional synthetic DNA origami needle‐like structure. This origami is functionalized with trastuzumab antibodies, cholesterol, protective polymers, and two dyes, which together enable selective targeting and insertion into SKBR3 cancer cells. A disulfide‐linked dye payload was attached to the apex of the needle, allowing controlled release in the cytoplasm triggered by the high intracellular glutathione concentration. Real‐time tracking of the payload confirmed both successful targeting of the origami structure and subsequent direct cytosolic delivery. By mimicking fundamental mechanisms of bacteriophages, we propose that this artificial needle structure can serve as a prototypical device for the targeted delivery of small‐molecule drugs directly into the cytosol.

We designed a synthetic DNA origami needle‐like structure inspired by bacteriophages for targeted drug delivery. Functionalized with trastuzumab antibodies, cholesterol, and dyes, it selectively targets SKBR3 cancer cells. A glutathione‐triggered dye payload enables controlled release, and delivery is verified using confocal microscopy and live cell tracking, confirming successful cytosolic delivery.

## Linked entities

- **Chemicals:** glutathione (PubChem CID 124886), disulfide (PubChem CID 108196)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** cancer (MESH:D009369)
- **Chemicals:** Origami Needle (-), trastuzumab (MESH:D000068878), disulfide (MESH:D004220), cholesterol (MESH:D002784), glutathione (MESH:D005978)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12915191/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12915191/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12915191/full.md

---
Source: https://tomesphere.com/paper/PMC12915191